AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 AUG 6 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Germany have identified an interferon (IFN) resistance gene whose expression is critical for modified vaccinia virus Ankara (MVA) replication.
Highly attenuated MVA "serves as a candidate vaccine to immunize against infectious diseases and cancer," including HIV infection, explained Simone Hornemann and colleagues at Ludwig Maximilians University in Munich and the Technical University of Munich.
A mutant form of MVA lacking expression of the IFN resistance gene E3L was unable to replicate in chicken embryo fibroblasts (CEF) used in experimental tissue cultures, Hornemann and coauthors found.
The researchers developed an MVA deletion mutant dubbed MVA-deltaE3L. This mutant did not have the ability to grow in CEF, a functional loss that was reversed by reinsertion of the missing E3L gene, according to the report.
DNA replication of MVA-deltaE3L was seen during nonproductive CEF infection, but viral protein synthesis was incomplete and infected cells underwent rapid apoptosis, study data showed. In additon, CEF infected with mutant MVA produced high levels of interferon (IFN)-alpha ...